Mesenchymal chondrosarcoma of the maxilla: Case report and clinicopathologic review  by Huang, Wen-Chih et al.
at SciVerse ScienceDirect
Tzu Chi Medical Journal 25 (2013) 55e57Contents lists availableTzu Chi Medical Journal
journal homepage: www.tzuchimedjnl .comCase Report
Mesenchymal chondrosarcoma of the maxilla: Case report and clinicopathologic
review
Wen-Chih Huang a, Kwang-Yu Hu b, Kuan-Ting Kuo c, Chien-Chen Tsai a,*
aDepartment of Anatomic Pathology, Far Eastern Memorial Hospital, New Taipei City, Taiwan
bDepartment of Oral Maxillofacial Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan
cDepartment of Pathology, National Taiwan University Hospital, Taipei, Taiwana r t i c l e i n f o
Article history:
Received 9 September 2012
Received in revised form
25 September 2012
Accepted 29 September 2012
Keywords:
Bone and cartilaginous tumor
Mesenchymal chondrosarcoma
Oral and maxillofacial pathologyConﬂict of interest: none.
* Corresponding author. Department of Anatom
Memorial Hospital, 21, Section 2, Nanya South Roa
Tel.: þ886 277282073; fax: þ886 277282060.
E-mail address: pathologytcc@gmail.com (C.-C. Ts
1016-3190/$ e see front matter Copyright  2012, Bu
http://dx.doi.org/10.1016/j.tcmj.2012.10.003a b s t r a c t
Mesenchymal chondrosarcoma is extremely rare, accounting for around 1% of all chondrosarcomas. It
occurs in the axial skeleton, the head and neck region and a high proportion of extraskeletal sites. Fewer
than 40 cases of mesenchymal chondrosarcoma in the maxilla have been reported in English literature.
The neoplasm is aggressive, with a high tendency for late recurrence and delayed distant metastasis.
Here we present a 50-year-old man with palatal mucosal swelling for 6 months. The initial clinical
impression was a benign minor salivary gland neoplasm. The biopsy revealed hyaline cartilage, alter-
nating with undifferentiated small round cells, pathognomonic for mesenchymal chondrosarcoma.
Diagnosis of biopsy specimens remains a challenge because of variable tumor components, and speci-
mens may contain only one of the two neoplastic elements. The patient received radical surgery and has
been disease free for 40 months. Clinicians and pathologists should be aware of this entity in the
differential diagnosis of maxillofacial neoplasms, to prevent misdiagnosis and delayed intervention.
Copyright  2012, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Mesenchymal chondrosarcoma is a rare subtype of chon-
drosarcoma among World Health Organization classiﬁcations and it
accounts foraround1%ofall chondrosarcomas [1,2]. The tumoraffects
a relatively young patient population compared with conventional
chondrosarcoma. The majority of mesenchymal chondrosarcomas
occur in theaxial skeleton.Theheadandneck region is alsoa common
site for the neoplasm [2,3]. The sinonasal tract has rarely been re-
ported and the maxillary sinus is the most commonly affected.
Commonly reported symptoms includeswelling,mass formation, and
nasal obstruction. Here we present a rare case of mesenchymal
chondrosarcoma originating in the maxilla and discuss the clinico-
pathological features.
2. Case report
A 50-year-old man presented with palatal mucosal swelling and
mild nasal obstruction for 6 months. He had initially visited a localic Pathology, Far Eastern
d, New Taipei City, Taiwan.
ai).
ddhist Compassion Relief Tzu Chiclinic with follow-up. On intraoral examination, one small elastic,
immobile nodule was noted in the palatal area. No epistaxis or
nasal discharge was noted and no enlarged neck lymphadenopathy
was observed. The laboratory data were within reference levels.
The initial clinical impression was a benign, minor salivary gland
neoplasm. An incisional biopsy was performed for histopatholog-
ical evaluation.
Microscopically, the biopsy revealed bland-looking hyaline
cartilage, admixed with undifferentiated, small round cells in the
stroma. The cartilage component was relatively well-differentiated
and the undifferentiated areas exhibited blue round cells. No sali-
vary component was observed. The picture was pathognomonic for
mesenchymal chondrosarcoma. Subsequent image studies were
done to stage the disease.
Magnetic resonance imaging revealed a T1-isointense, T2-
hypointense 5 cm mass lesion in the left maxillary-alveolar area,
involving the nasomaxillary lamina and hard palate (Fig. 1A). The
lesion exhibited prominent contrast enhancement (Fig. 1B). Further
specimens, taken during radical surgery, disclosed a tan tumor,
4.8 cm in diameter, mainly in the left maxilla (Fig. 2A).
The histopathological features revealed a picture of mesen-
chymal chondrosarcoma, composed of biphasic patterns with
hyaline cartilage and undifferentiated small blue round cells
(Fig. 2B). The proportions of the two components were relativelyFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Magnetic resonance imaging displays a 5 cm mass lesion in the left maxillary-alveolar area; (B) the lesion exhibits contrast enhancement.
W.-C. Huang et al. / Tzu Chi Medical Journal 25 (2013) 55e5756equal. The transition of the two patterns was abrupt in some
regions and gradual in other areas. The hyaline cartilage component
was well-differentiated and benign-appearing, with minimal aty-
pia. These small cells exhibited round to oval hyperchromatic nuclei
(Fig. 2C), with a focal hemangiopericytomatous-like vascular
pattern (Fig. 2D). Immunohistochemically, the chondroid areas
were positive for S-100 protein. The blue round cells were reactive
for CD99. The lesion was mainly located in the left maxillary alve-
olar area, invading the hard palate and soft tissue. The section
margins were free of disease. The patient has been followed up for
40 months, with no evidence of recurrence.Fig. 2. (A) The tumor is tan and ﬁrm, mainly in the left maxilla, and bulges into the left pa
small round cells (hematoxylin-eosin stain, 100); (C) a small blue round cell area (hemato
(hematoxylin-eosin stain, 100).3. Discussion
Mesenchymal chondrosarcoma is a rare subtype of chon-
drosarcoma [1,2]. It shows no sex predilection. Mesenchymal
chondrosarcoma is regarded as a high-grade sarcoma in the
grading systems of the French Federation of Cancer Centers
Sarcoma Group, the National Cancer Institute and the WHO clas-
siﬁcation [4]. Themajority of mesenchymal chondrosarcomas occur
in the axial skeleton. It may occur in the head and neck region, with
a predilection for the maxillofacial skeleton [2,3]. The sinonasal
tract has rarely been reported and the maxillary sinus is mostlatal mucosa; (B) biphasic patterns of hyaline cartilage blending with undifferentiated
xylin-eosin stain, 400); (D) there is a hemangiopericytomatous-like vascular pattern
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drosarcoma originating in the maxilla have been reported in
English literature [5].
Computed tomography demonstrates a well-deﬁned mass, with
stippled calciﬁed areas. Magnetic resonance imaging ﬁndings can
be quite variable. The noncalciﬁed areas demonstrate isointense to
hypointense signal intensity on T1-weighted images and are
hyperintense on T2-weighted images. Images after gadolinium
contrast reveal inhomogeneous enhancement. The ﬁndings also
include variable calciﬁcation, hypervascularity, lobulation, and
bony destruction [2,6].
The tumor is typically large in the axial skeleton and relatively
smaller in the maxillofacial regions and sinonasal tract [2]. The cut
surface shows blue-gray fragments, with focal hemorrhagic areas.
Microscopically, a biphasic pattern of well-differentiated chondroid
elements, with an abrupt boundary from undifferentiated small
round cells, is pathognomonic of the neoplasm. Focal myxoid
degeneration and hemorrhagic necrosis may be observed. Tumor
cells around vessels with a hemangiopericytoma-like growth
pattern are common. Immunohistochemically, the small round
cells are positive for CD99. The chondroid areas are positive for S-
100 protein.
Diagnosis of biopsy specimens remains a challenge because of
the variable tumor components and specimens may contain only
one of the two elements. In one clinical series, only 38% of cases
were accurately diagnosed on initial analysis [7]. The differential
diagnosis includes a small blue round cell neoplasm as Ewing’s
sarcoma/primitive neuroectodermal tumors, small cell osteosar-
coma, embryonal rhabdomyosarcoma, and lymphoma [2,5,7]. The
identiﬁcation of chondroid matrix and undifferentiated mesen-
chymal cells is crucial for an accurate diagnosis.
The primary treatment modality is radical surgery with wide
safe margins. The overall role of multimodality treatment with
radiation and/or systemic chemotherapy remains uncertain [2,8e
10]. Mesenchymal chondrosarcoma has a tendency towards both
local and distant recurrence [2,8]. The tumor affects a relatively
younger patient population compared with conventional chon-
drosarcoma. There is also a high proportion of extraskeletalprimary tumors, which are not observed with other chon-
drosarcoma subtypes [10]. The prognosis is markedly worse than
for conventional primary chondrosarcomas, with 10-year survival
rates of 20e30% [2,8]. A few series revealed better prognosis than
other historical results with the tumors located in the sinonasal
tract and jaws [3,7,9]. This could be attributed to more favorable
tumor characteristics (e.g., smaller tumors). It is crucial to gain
more information on the clinical behavior, pathogenesis, cytoge-
netic study and treatment frommore series and prospective data of
this rare neoplasm. Clinicians and pathologists should be aware of
this rare entity in the differential diagnosis of maxillofacial
neoplasm, to prevent misdiagnosis and delayed intervention.
References
[1] Koch BB, Karnell LH, Hoffman HT, Apostolakis LW, Robinson RA, Zhen W, et al.
National cancer database report on chondrosarcoma of the head and neck.
Head Neck 2000;22:408e25.
[2] Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chon-
drosarcoma of bone and soft tissue: a review of 111 cases. Cancer 1986;57:
2444e53.
[3] Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chon-
drosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer
1998;82:2350e5.
[4] Nakashima Y, Park YK, Sugano O. Mesenchymal chondrosarcoma. In:
Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics of tumours
of soft tissues and bone. World Health Organization classiﬁcation of tumours.
Lyon: IARC; 2002. p. 255e6.
[5] Tien N, Chaisuparat R, Fernandes R, Sarlani E, Papadimitriou JC, Ord RA, et al.
Mesenchymal chondrosarcoma of the maxilla: case report and literature
review. J Oral Maxillofac Surg 2007;65:1260e6.
[6] Shapeero LG, Vanel D, Couanet D, Contesso G, Ackerman LV. Extraskeletal
mesenchymal chondrosarcoma. Radiology 1993;186:819e26.
[7] Knott PD, Gannon FH, Thompson LD. Mesenchymal chondrosarcoma of the
sinonasal tract: a clinicopathological study of 13 cases with a review of the
literature. Laryngoscope 2003;113:783e90.
[8] Harwood AR, Krajbich JI, Fornasier VL. Mesenchymal chondrosarcoma:
a report of 17 cases. Clin Orthop Relat Res 1981;158:144e8.
[9] Takahashi K, Sato K, Kanazawa H, Wang XL, Kimura T. Mesenchymal chon-
drosarcoma of the jaw e report of a case and review of 41 cases in the
literature. Head Neck 1993;15:459e64.
[10] Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Futwaengler R, Claviez A,
et al. Mesenchymal chondrosarcoma of soft tissues and bone in children,
adolescents, and young adults: experiences of the CWS and COSS study
groups. Cancer 2008;112:2424e31.
